Table 3.
Young ST-elevation myocardial infarction (STEMI) profile, times to treatment, in-hospital events, and discharge data.
| Variable | n | % |
|---|---|---|
| STEMI site, n = 76 | ||
| Anterior | 36 | 47.4 |
| Inferior | 23 | 30.3 |
| Inferoposterior | 6 | 7.9 |
| Anterolateral | 5 | 6.6 |
| Anteroseptal | 2 | 2.6 |
| Inferolateral | 2 | 2.6 |
| Antero-inferior | 1 | 1.3 |
| Infero-septal | 1 | 1.3 |
| Single vessel, n = 76 | 47 | 61.8 |
| Multiple vessel, n = 76 | 29 | 38.2 |
| Stent type, n = 77 | ||
| Drug-eluting stent | 56 | 72.7 |
| Bare-metal stent | 9 | 11.7 |
| POBA | 7 | 9.1 |
| Angiography only/no flow restriction | 5 | 6.5 |
| In-hospital events, n = 77 | ||
| Death | 2 | 7.5 |
| Arrest | 5 | 6.5 |
| Bypass graft | 1 | 1.3 |
| Intra-aortic balloon pump | 1 | 1.3 |
| Reinfarction | 0 | 0.0 |
| Bleed | 0 | 0.0 |
| Stent thrombosis | 0 | 0.0 |
| Times to treatment | Median, IQRb | |
| Door to ECG | 77 | 5.0, (2.0, 8.0) |
| Door to balloon | 71 | 70.0, (54.0, 88.0) |
| ISHC | 71 | 233.0, (130.0, 467.0) |
| D in coronary care unit | 77 | 5.0, (4.0, 6.0) |
| Discharge status, n = 75a | n | % |
| To home | 75 | 100.0 |
| Statins | 71 | 94.7 |
| Beta blocker | 68 | 90.7 |
| Clopidogrel | 64 | 85.3 |
| ACE inbitor | 53 | 70.7 |
| Nitrates | 15 | 20.0 |
| Aspirin | 9 | 12.0 |
| Ticagrelor | 9 | 12.0 |
| Angiotensin 2 receptor blocking drug | 3 | 4.0 |
| Warfarin | 3 | 4.0 |
| Antiarrhythmic | 2 | 2.7 |
| Digoxin | 2 | 2.7 |
| Diuretics | 2 | 2.7 |
| Ca channel blocker | 1 | 1.3 |
| Insulin | 1 | 1.3 |
ACE = angiotensin-converting enzyme; ECG = electrocardiography; IQR = interquartile range; ISHC = Total Ischemic Time; POBA = plain old balloon angioplasty.
a
Two of the patients were deceased, the n and% are for the remaining 75.
b
First quartile, third quartile.